Mucosal vaccines

References

• Sato S, Kiyono H. The mucosal immune system of the respiratory tract. Current opinion in virology 2012; 2:225-32.
   Google Scholar
• Brandtzaeg P. Mucosal immunity: induction, dissemination, and effector functions. Scand J Immunol 2009; 70:505 - 15; http://dx.doi.org/10.1111/j.1365-3083.2009.02319.x; PMID: 19906191
   PubMed Web of Science ®Google Scholar
• Takahashi I, Nochi T, Yuki Y, Kiyono H. New horizon of mucosal immunity and vaccines. Curr Opin Immunol 2009; 21:352 - 8; http://dx.doi.org/10.1016/j.coi.2009.04.002; PMID: 19493665
   PubMed Web of Science ®Google Scholar
• Atmar RL, Bernstein DI, Harro CD, Al-Ibrahim MS, Chen WH, Ferreira J, Estes MK, Graham DY, Opekun AR, Richardson C, et al. Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med 2011; 365:2178 - 87; http://dx.doi.org/10.1056/NEJMoa1101245; PMID: 22150036
   PubMed Web of Science ®Google Scholar
• http://www.clinicaltrials.gov/ct.
   Google Scholar
• Nardelli-Haefliger D, Dudda JC, Romero P. Vaccination route matters for mucosal tumors. Science translational medicine 2013; 5:172fs4.
   Google Scholar
• Badoual C, Sandoval F, Pere H, Hans S, Gey A, Merillon N, Van Ryswick C, Quintin-Colonna F, Bruneval P, Brasnu D, et al. Better understanding tumor-host interaction in head and neck cancer to improve the design and development of immunotherapeutic strategies. Head Neck 2010; 32:946 - 58; PMID: 20191626
   PubMed Web of Science ®Google Scholar
• Kiyono H, Fukuyama S. NALT- versus Peyer’s-patch-mediated mucosal immunity. Nat Rev Immunol 2004; 4:699 - 710; http://dx.doi.org/10.1038/nri1439; PMID: 15343369
   PubMed Web of Science ®Google Scholar
• Nizard M, Sandoval F, Badoual C, Pere H, Terme M, Hans S, Benhamouda N, Granier C, Brasnu D, Tartour E. Immunotherapy of HPV-associated head and neck cancer: Critical parameters. Oncoimmunology 2013; 2:e24534; http://dx.doi.org/10.4161/onci.24534; PMID: 23894716
   PubMed Web of Science ®Google Scholar
• Cesta MF. Normal structure, function, and histology of mucosa-associated lymphoid tissue. Toxicol Pathol 2006; 34:599 - 608; http://dx.doi.org/10.1080/01926230600865531; PMID: 17067945
   PubMed Web of Science ®Google Scholar
• Tschernig T, Pabst R. Bronchus-associated lymphoid tissue (BALT) is not present in the normal adult lung but in different diseases. Pathobiology 2000; 68:1 - 8; http://dx.doi.org/10.1159/000028109; PMID: 10859525
   PubMed Web of Science ®Google Scholar
• Dieu-Nosjean MC, Antoine M, Danel C, Heudes D, Wislez M, Poulot V, Rabbe N, Laurans L, Tartour E, de Chaisemartin L, et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2008; 26:4410-7.
   Google Scholar
• Pavot V, Rochereau N, Genin C, Verrier B, Paul S. New insights in mucosal vaccine development. Vaccine 2012; 30:142 - 54; http://dx.doi.org/10.1016/j.vaccine.2011.11.003; PMID: 22085556
   PubMed Web of Science ®Google Scholar
• Abreu MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease. J Immunol 2005; 174:4453 - 60; http://dx.doi.org/10.4049/jimmunol.174.8.4453; PMID: 15814663
   PubMed Web of Science ®Google Scholar
• Fritz JH, Le Bourhis L, Magalhaes JG, Philpott DJ. Innate immune recognition at the epithelial barrier drives adaptive immunity: APCs take the back seat. Trends Immunol 2008; 29:41 - 9; http://dx.doi.org/10.1016/j.it.2007.10.002; PMID: 18054284
   PubMed Web of Science ®Google Scholar
• Kraehenbuhl JP, Neutra MR. Epithelial M cells: differentiation and function. Annu Rev Cell Dev Biol 2000; 16:301 - 32; http://dx.doi.org/10.1146/annurev.cellbio.16.1.301; PMID: 11031239
   PubMed Web of Science ®Google Scholar
• Siebers A, Finlay BB. M cells and the pathogenesis of mucosal and systemic infections. Trends Microbiol 1996; 4:22 - 9; http://dx.doi.org/10.1016/0966-842X(96)81501-0; PMID: 8824791
   PubMed Web of Science ®Google Scholar
• Contractor N, Louten J, Kim L, Biron CA, Kelsall BL. Cutting edge: Peyer’s patch plasmacytoid dendritic cells (pDCs) produce low levels of type I interferons: possible role for IL-10, TGFbeta, and prostaglandin E2 in conditioning a unique mucosal pDC phenotype. J Immunol 2007; 179:2690 - 4; http://dx.doi.org/10.4049/jimmunol.179.5.2690; PMID: 17709480
   PubMed Web of Science ®Google Scholar
• Salazar-Gonzalez RM, Niess JH, Zammit DJ, Ravindran R, Srinivasan A, Maxwell JR, Stoklasek T, Yadav R, Williams IR, Gu X, et al. CCR6-mediated dendritic cell activation of pathogen-specific T cells in Peyer’s patches. Immunity 2006; 24:623 - 32; http://dx.doi.org/10.1016/j.immuni.2006.02.015; PMID: 16713979
   PubMed Web of Science ®Google Scholar
• Iwasaki A, Kelsall BL. Unique functions of CD11b+, CD8 alpha+, and double-negative Peyer’s patch dendritic cells. J Immunol 2001; 166:4884 - 90; http://dx.doi.org/10.4049/jimmunol.166.8.4884; PMID: 11290765
   PubMed Web of Science ®Google Scholar
• Johansson-Lindbom B, Svensson M, Wurbel MA, Malissen B, Márquez G, Agace W. Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. J Exp Med 2003; 198:963 - 9; http://dx.doi.org/10.1084/jem.20031244; PMID: 12963696
   PubMed Web of Science ®Google Scholar
• Jaensson E, Uronen-Hansson H, Pabst O, Eksteen B, Tian J, Coombes JL, Berg PL, Davidsson T, Powrie F, Johansson-Lindbom B, et al. Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. J Exp Med 2008; 205:2139 - 49; http://dx.doi.org/10.1084/jem.20080414; PMID: 18710932
   PubMed Web of Science ®Google Scholar
• Svensson M, Johansson-Lindbom B, Zapata F, Jaensson E, Austenaa LM, Blomhoff R, Agace WW. Retinoic acid receptor signaling levels and antigen dose regulate gut homing receptor expression on CD8+ T cells. Mucosal Immunol 2008; 1:38 - 48; http://dx.doi.org/10.1038/mi.2007.4; PMID: 19079159
   PubMed Web of Science ®Google Scholar
• Baker K, Rath T, Flak MB, Arthur JC, Chen Z, Glickman JN, Zlobec I, Karamitopoulou E, Stachler MD, Odze RD, et al. Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancer. Immunity 2013; 39:1095 - 107; http://dx.doi.org/10.1016/j.immuni.2013.11.003; PMID: 24290911
   PubMed Web of Science ®Google Scholar
• Cerutti A. The regulation of IgA class switching. Nat Rev Immunol 2008; 8:421 - 34; http://dx.doi.org/10.1038/nri2322; PMID: 18483500
   PubMed Web of Science ®Google Scholar
• Strugnell RA, Wijburg OL. The role of secretory antibodies in infection immunity. Nat Rev Microbiol 2010; 8:656 - 67; http://dx.doi.org/10.1038/nrmicro2384; PMID: 20694027
   PubMed Web of Science ®Google Scholar
• Pasetti MF, Simon JK, Sztein MB, Levine MM. Immunology of gut mucosal vaccines. Immunol Rev 2011; 239:125 - 48; http://dx.doi.org/10.1111/j.1600-065X.2010.00970.x; PMID: 21198669
   PubMed Web of Science ®Google Scholar
• Hammerschmidt SI, Ahrendt M, Bode U, Wahl B, Kremmer E, Förster R, Pabst O. Stromal mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo. J Exp Med 2008; 205:2483 - 90; http://dx.doi.org/10.1084/jem.20080039; PMID: 18852290
   PubMed Web of Science ®Google Scholar
• Mueller SN, Germain RN. Stromal cell contributions to the homeostasis and functionality of the immune system. Nat Rev Immunol 2009; 9:618 - 29; PMID: 19644499
   PubMed Web of Science ®Google Scholar
• Mora JR, Iwata M, Eksteen B, Song SY, Junt T, Senman B, Otipoby KL, Yokota A, Takeuchi H, Ricciardi-Castagnoli P, et al. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 2006; 314:1157 - 60; http://dx.doi.org/10.1126/science.1132742; PMID: 17110582
   PubMed Web of Science ®Google Scholar
• Gohda M, Kunisawa J, Miura F, Kagiyama Y, Kurashima Y, Higuchi M, Ishikawa I, Ogahara I, Kiyono H. Sphingosine 1-phosphate regulates the egress of IgA plasmablasts from Peyer’s patches for intestinal IgA responses. J Immunol 2008; 180:5335 - 43; http://dx.doi.org/10.4049/jimmunol.180.8.5335; PMID: 18390715
   PubMed Web of Science ®Google Scholar
• Kaetzel CS. The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces. Immunol Rev 2005; 206:83 - 99; http://dx.doi.org/10.1111/j.0105-2896.2005.00278.x; PMID: 16048543
   PubMed Web of Science ®Google Scholar
• McGuckin MA, Lindén SK, Sutton P, Florin TH. Mucin dynamics and enteric pathogens. Nat Rev Microbiol 2011; 9:265 - 78; http://dx.doi.org/10.1038/nrmicro2538; PMID: 21407243
   PubMed Web of Science ®Google Scholar
• Kunisawa J, Nochi T, Kiyono H. Immunological commonalities and distinctions between airway and digestive immunity. Trends Immunol 2008; 29:505 - 13; http://dx.doi.org/10.1016/j.it.2008.07.008; PMID: 18835748
   PubMed Web of Science ®Google Scholar
• Meeusen EN. Exploiting mucosal surfaces for the development of mucosal vaccines. Vaccine 2011; 29:8506 - 11; http://dx.doi.org/10.1016/j.vaccine.2011.09.010; PMID: 21945494
   PubMed Web of Science ®Google Scholar
• Mantis NJ, Rol N, Corthésy B. Secretory IgA’s complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol 2011; 4:603 - 11; http://dx.doi.org/10.1038/mi.2011.41; PMID: 21975936
   PubMed Web of Science ®Google Scholar
• Sminia T, van der Brugge-Gamelkoorn GJ, Jeurissen SH. Structure and function of bronchus-associated lymphoid tissue (BALT). Crit Rev Immunol 1989; 9:119 - 50; PMID: 2663024
   PubMed Web of Science ®Google Scholar
• Sigmundsdottir H, Butcher EC. Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nat Immunol 2008; 9:981 - 7; http://dx.doi.org/10.1038/ni.f.208; PMID: 18711435
   PubMed Web of Science ®Google Scholar
• Masopust D, Vezys V, Usherwood EJ, Cauley LS, Olson S, Marzo AL, Ward RL, Woodland DL, Lefrançois L. Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin. J Immunol 2004; 172:4875 - 82; http://dx.doi.org/10.4049/jimmunol.172.8.4875; PMID: 15067066
   PubMed Web of Science ®Google Scholar
• Ariotti S, Haanen JB, Schumacher TN. Behavior and function of tissue-resident memory T cells. Adv Immunol 2012; 114:203 - 16; http://dx.doi.org/10.1016/B978-0-12-396548-6.00008-1; PMID: 22449783
   PubMed Web of Science ®Google Scholar
• Gebhardt T, Wakim LM, Eidsmo L, Reading PC, Heath WR, Carbone FR. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat Immunol 2009; 10:524 - 30; http://dx.doi.org/10.1038/ni.1718; PMID: 19305395
   PubMed Web of Science ®Google Scholar
• Khanna KM, Bonneau RH, Kinchington PR, Hendricks RL. Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. Immunity 2003; 18:593 - 603; http://dx.doi.org/10.1016/S1074-7613(03)00112-2; PMID: 12753737
   PubMed Web of Science ®Google Scholar
• Wakim LM, Waithman J, van Rooijen N, Heath WR, Carbone FR. Dendritic cell-induced memory T cell activation in nonlymphoid tissues. Science 2008; 319:198 - 202; http://dx.doi.org/10.1126/science.1151869; PMID: 18187654
   PubMed Web of Science ®Google Scholar
• Teijaro JR, Turner D, Pham Q, Wherry EJ, Lefrançois L, Farber DL. Cutting edge: Tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection. J Immunol 2011; 187:5510 - 4; http://dx.doi.org/10.4049/jimmunol.1102243; PMID: 22058417
   PubMed Web of Science ®Google Scholar
• Purwar R, Campbell J, Murphy G, Richards WG, Clark RA, Kupper TS. Resident memory T cells (T(RM)) are abundant in human lung: diversity, function, and antigen specificity. PLoS One 2011; 6:e16245; http://dx.doi.org/10.1371/journal.pone.0016245; PMID: 21298112
   PubMedGoogle Scholar
• Hofmann M, Pircher H. E-cadherin promotes accumulation of a unique memory CD8 T-cell population in murine salivary glands. Proc Natl Acad Sci U S A 2011; 108:16741 - 6; http://dx.doi.org/10.1073/pnas.1107200108; PMID: 21930933
   PubMed Web of Science ®Google Scholar
• Masopust D, Choo D, Vezys V, Wherry EJ, Duraiswamy J, Akondy R, Wang J, Casey KA, Barber DL, Kawamura KS, et al. Dynamic T cell migration program provides resident memory within intestinal epithelium. J Exp Med 2010; 207:553 - 64; http://dx.doi.org/10.1084/jem.20090858; PMID: 20156972
   PubMed Web of Science ®Google Scholar
• Masopust D, Schenkel JM. The integration of T cell migration, differentiation and function. Nat Rev Immunol 2013; 13:309 - 20; http://dx.doi.org/10.1038/nri3442; PMID: 23598650
   PubMed Web of Science ®Google Scholar
• Carbone FR, Mackay LK, Heath WR, Gebhardt T. Distinct resident and recirculating memory T cell subsets in non-lymphoid tissues. Curr Opin Immunol 2013; 25:329 - 33; http://dx.doi.org/10.1016/j.coi.2013.05.007; PMID: 23746791
   PubMed Web of Science ®Google Scholar
• Woodland DL, Kohlmeier JE. Migration, maintenance and recall of memory T cells in peripheral tissues. Nat Rev Immunol 2009; 9:153 - 61; http://dx.doi.org/10.1038/nri2496; PMID: 19240755
   PubMed Web of Science ®Google Scholar
• Belyakov IM, Kuznetsov VA, Kelsall B, Klinman D, Moniuszko M, Lemon M, Markham PD, Pal R, Clements JD, Lewis MG, et al. Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa. Blood 2006; 107:3258 - 64; http://dx.doi.org/10.1182/blood-2005-11-4374; PMID: 16373659
   PubMed Web of Science ®Google Scholar
• Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. Retinoic acid imprints gut-homing specificity on T cells. Immunity 2004; 21:527 - 38; http://dx.doi.org/10.1016/j.immuni.2004.08.011; PMID: 15485630
   PubMed Web of Science ®Google Scholar
• Sigmundsdottir H, Pan J, Debes GF, Alt C, Habtezion A, Soler D, Butcher EC. DCs metabolize sunlight-induced vitamin D3 to ‘program’ T cell attraction to the epidermal chemokine CCL27. Nat Immunol 2007; 8:285 - 93; http://dx.doi.org/10.1038/ni1433; PMID: 17259988
   PubMed Web of Science ®Google Scholar
• Stagg AJ, Kamm MA, Knight SC. Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin. Eur J Immunol 2002; 32:1445 - 54; http://dx.doi.org/10.1002/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E; PMID: 11981833
   PubMed Web of Science ®Google Scholar
• Kunkel EJ, Campbell JJ, Haraldsen G, Pan J, Boisvert J, Roberts AI, Ebert EC, Vierra MA, Goodman SB, Genovese MC, et al. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J Exp Med 2000; 192:761 - 8; http://dx.doi.org/10.1084/jem.192.5.761; PMID: 10974041
   PubMed Web of Science ®Google Scholar
• Campbell DJ, Butcher EC. Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues. J Exp Med 2002; 195:135 - 41; http://dx.doi.org/10.1084/jem.20011502; PMID: 11781372
   PubMed Web of Science ®Google Scholar
• Dudda JC, Simon JC, Martin S. Dendritic cell immunization route determines CD8+ T cell trafficking to inflamed skin: role for tissue microenvironment and dendritic cells in establishment of T cell-homing subsets. J Immunol 2004; 172:857 - 63; http://dx.doi.org/10.4049/jimmunol.172.2.857; PMID: 14707056
   PubMed Web of Science ®Google Scholar
• Lycke N. Recent progress in mucosal vaccine development: potential and limitations. Nat Rev Immunol 2012; 12:592 - 605; http://dx.doi.org/10.1038/nri3251; PMID: 22828912
   PubMed Web of Science ®Google Scholar
• Gallichan WS, Rosenthal KL. Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization. J Exp Med 1996; 184:1879 - 90; http://dx.doi.org/10.1084/jem.184.5.1879; PMID: 8920875
   PubMed Web of Science ®Google Scholar
• Belyakov IM, Derby MA, Ahlers JD, Kelsall BL, Earl P, Moss B, Strober W, Berzofsky JA. Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. Proc Natl Acad Sci U S A 1998; 95:1709 - 14; http://dx.doi.org/10.1073/pnas.95.4.1709; PMID: 9465081
   PubMed Web of Science ®Google Scholar
• Macpherson AJ, McCoy KD, Johansen FE, Brandtzaeg P. The immune geography of IgA induction and function. Mucosal Immunol 2008; 1:11 - 22; http://dx.doi.org/10.1038/mi.2007.6; PMID: 19079156
   PubMed Web of Science ®Google Scholar
• Kunkel EJ, Kim CH, Lazarus NH, Vierra MA, Soler D, Bowman EP, Butcher EC. CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. J Clin Invest 2003; 111:1001 - 10; http://dx.doi.org/10.1172/JCI17244; PMID: 12671049
   PubMed Web of Science ®Google Scholar
• Pan J, Kunkel EJ, Gosslar U, Lazarus N, Langdon P, Broadwell K, Vierra MA, Genovese MC, Butcher EC, Soler D. A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues. J Immunol 2000; 165:2943 - 9; http://dx.doi.org/10.4049/jimmunol.165.6.2943; PMID: 10975800
   PubMed Web of Science ®Google Scholar
• Cha HR, Ko HJ, Kim ED, Chang SY, Seo SU, Cuburu N, Ryu S, Kim S, Kweon MN. Mucosa-associated epithelial chemokine/CCL28 expression in the uterus attracts CCR10+ IgA plasma cells following mucosal vaccination via estrogen control. J Immunol 2011; 187:3044 - 52; http://dx.doi.org/10.4049/jimmunol.1100402; PMID: 21832166
   PubMed Web of Science ®Google Scholar
• Hervouet C, Luci C, Cuburu N, Cremel M, Bekri S, Vimeux L, Marañon C, Czerkinsky C, Hosmalin A, Anjuère F. Sublingual immunization with an HIV subunit vaccine induces antibodies and cytotoxic T cells in the mouse female genital tract. Vaccine 2010; 28:5582 - 90; http://dx.doi.org/10.1016/j.vaccine.2010.06.033; PMID: 20600505
   PubMed Web of Science ®Google Scholar
• Ruane D, Brane L, Reis BS, Cheong C, Poles J, Do Y, Zhu H, Velinzon K, Choi JH, Studt N, et al. Lung dendritic cells induce migration of protective T cells to the gastrointestinal tract. J Exp Med 2013; 210:1871 - 88; http://dx.doi.org/10.1084/jem.20122762; PMID: 23960190
   PubMed Web of Science ®Google Scholar
• Hervouet C, Luci C, Bekri S, Juhel T, Bihl F, Braud VM, Czerkinsky C, Anjuère F. Antigen-bearing dendritic cells from the sublingual mucosa recirculate to distant systemic lymphoid organs to prime mucosal CD8 T cells. Mucosal Immunol 2014; 7:280 - 91; http://dx.doi.org/10.1038/mi.2013.45; PMID: 23801305
   PubMed Web of Science ®Google Scholar
• Marks E, Helgeby A, Andersson JO, Schön K, Lycke NY. CD4⁺ T-cell immunity in the female genital tract is critically dependent on local mucosal immunization. Eur J Immunol 2011; 41:2642 - 53; http://dx.doi.org/10.1002/eji.201041297; PMID: 21681740
   PubMed Web of Science ®Google Scholar
• Rudin A, Johansson EL, Bergquist C, Holmgren J. Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humans. Infect Immun 1998; 66:3390 - 6; PMID: 9632610
   PubMed Web of Science ®Google Scholar
• Chung H, Pamp SJ, Hill JA, Surana NK, Edelman SM, Troy EB, Reading NC, Villablanca EJ, Wang S, Mora JR, et al. Gut immune maturation depends on colonization with a host-specific microbiota. Cell 2012; 149:1578 - 93; http://dx.doi.org/10.1016/j.cell.2012.04.037; PMID: 22726443
   PubMed Web of Science ®Google Scholar
• Kamada N, Núñez G. Regulation of the immune system by the resident intestinal bacteria. Gastroenterology 2014; 146:1477 - 88; http://dx.doi.org/10.1053/j.gastro.2014.01.060; PMID: 24503128
   PubMed Web of Science ®Google Scholar
• Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010; 362:289 - 98; http://dx.doi.org/10.1056/NEJMoa0904797; PMID: 20107214
   PubMed Web of Science ®Google Scholar
• Mora JR, Bono MR, Manjunath N, Weninger W, Cavanagh LL, Rosemblatt M, Von Andrian UH. Selective imprinting of gut-homing T cells by Peyer’s patch dendritic cells. Nature 2003; 424:88 - 93; http://dx.doi.org/10.1038/nature01726; PMID: 12840763
   PubMed Web of Science ®Google Scholar
• Luiz WB, Cavalcante RC, Paccez JD, Souza RD, Sbrogio-Almeida ME, Ferreira RC, Ferreira LC. Boosting systemic and secreted antibody responses in mice orally immunized with recombinant Bacillus subtilis strains following parenteral priming with a DNA vaccine encoding the enterotoxigenic Escherichia coli (ETEC) CFA/I fimbriae B subunit. Vaccine 2008; 26:3998 - 4005; http://dx.doi.org/10.1016/j.vaccine.2008.05.030; PMID: 18597902
   PubMed Web of Science ®Google Scholar
• Im EJ, Borducchi EN, Provine NM, McNally AG, Li S, Frankel FR, Barouch DH. An attenuated Listeria monocytogenes vector primes more potent simian immunodeficiency virus-specific mucosal immunity than DNA vaccines in mice. J Virol 2013; 87:4751 - 5; http://dx.doi.org/10.1128/JVI.03085-12; PMID: 23388715
   PubMed Web of Science ®Google Scholar
• Neeson P, Boyer J, Kumar S, Lewis MG, Mattias L, Veazey R, Weiner D, Paterson Y. A DNA prime-oral Listeria boost vaccine in rhesus macaques induces a SIV-specific CD8 T cell mucosal response characterized by high levels of alpha4beta7 integrin and an effector memory phenotype. Virology 2006; 354:299 - 315; http://dx.doi.org/10.1016/j.virol.2006.06.036; PMID: 16904153
   PubMed Web of Science ®Google Scholar
• Ribelles P, Benbouziane B, Langella P, Suárez JE, Bermúdez-Humarán LG. Protection against human papillomavirus type 16-induced tumors in mice using non-genetically modified lactic acid bacteria displaying E7 antigen at its surface. Appl Microbiol Biotechnol 2013; 97:1231 - 9; http://dx.doi.org/10.1007/s00253-012-4575-1; PMID: 23212671
   PubMed Web of Science ®Google Scholar
• Nardelli-Haefliger D, Roden RB, Benyacoub J, Sahli R, Kraehenbuhl JP, Schiller JT, Lachat P, Potts A, De Grandi P. Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice. Infect Immun 1997; 65:3328 - 36; PMID: 9234794
   PubMed Web of Science ®Google Scholar
• Hemann EA, Kang SM, Legge KL. Protective CD8 T cell-mediated immunity against influenza A virus infection following influenza virus-like particle vaccination. J Immunol 2013; 191:2486 - 94; http://dx.doi.org/10.4049/jimmunol.1300954; PMID: 23885108
   PubMed Web of Science ®Google Scholar
• Price GE, Soboleski MR, Lo CY, Misplon JA, Quirion MR, Houser KV, Pearce MB, Pappas C, Tumpey TM, Epstein SL. Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses. PLoS One 2010; 5:e13162; http://dx.doi.org/10.1371/journal.pone.0013162; PMID: 20976273
   PubMed Web of Science ®Google Scholar
• Baron SD, Singh R, Metzger DW. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion. Infect Immun 2007; 75:2152 - 62; http://dx.doi.org/10.1128/IAI.01606-06; PMID: 17296747
   PubMed Web of Science ®Google Scholar
• Sui Z, Chen Q, Fang F, Zheng M, Chen Z. Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant. Vaccine 2010; 28:7690 - 8; http://dx.doi.org/10.1016/j.vaccine.2010.09.019; PMID: 20870054
   PubMed Web of Science ®Google Scholar
• Zygmunt BM, Rharbaoui F, Groebe L, Guzman CA. Intranasal immunization promotes th17 immune responses. J Immunol 2009; 183:6933 - 8; http://dx.doi.org/10.4049/jimmunol.0901144; PMID: 19890060
   PubMed Web of Science ®Google Scholar
• Iwakura Y, Ishigame H, Saijo S, Nakae S. Functional specialization of interleukin-17 family members. Immunity 2011; 34:149 - 62; http://dx.doi.org/10.1016/j.immuni.2011.02.012; PMID: 21349428
   PubMed Web of Science ®Google Scholar
• Ashkenazi S, Vertruyen A, Arístegui J, Esposito S, McKeith DD, Klemola T, Biolek J, Kühr J, Bujnowski T, Desgrandchamps D, et al, CAIV-T Study Group. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J 2006; 25:870 - 9; http://dx.doi.org/10.1097/01.inf.0000237829.66310.85; PMID: 17006279
   PubMed Web of Science ®Google Scholar
• Song JH, Nguyen HH, Cuburu N, Horimoto T, Ko SY, Park SH, Czerkinsky C, Kweon MN. Sublingual vaccination with influenza virus protects mice against lethal viral infection. Proc Natl Acad Sci U S A 2008; 105:1644 - 9; http://dx.doi.org/10.1073/pnas.0708684105; PMID: 18227512
   PubMed Web of Science ®Google Scholar
• Kim SH, Kim JY, Choi Y, Nguyen HH, Song MK, Chang J. Mucosal vaccination with recombinant adenovirus encoding nucleoprotein provides potent protection against influenza virus infection. PLoS One 2013; 8:e75460; http://dx.doi.org/10.1371/journal.pone.0075460; PMID: 24086536
   PubMed Web of Science ®Google Scholar
• Çuburu N, Graham BS, Buck CB, Kines RC, Pang YY, Day PM, Lowy DR, Schiller JT. Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses. J Clin Invest 2012; 122:4606 - 20; http://dx.doi.org/10.1172/JCI63287; PMID: 23143305
   PubMed Web of Science ®Google Scholar
• Shim BS, Choi Y, Cheon IS, Song MK. Sublingual delivery of vaccines for the induction of mucosal immunity. Immune Netw 2013; 13:81 - 5; http://dx.doi.org/10.4110/in.2013.13.3.81; PMID: 23885221
   PubMedGoogle Scholar
• Pedersen G, Cox R. The mucosal vaccine quandary: intranasal vs. sublingual immunization against influenza. Hum Vaccin Immunother 2012; 8:689 - 93; http://dx.doi.org/10.4161/hv.19568; PMID: 22495121
   PubMed Web of Science ®Google Scholar
• Huo Z, Bissett SL, Giemza R, Beddows S, Oeser C, Lewis DJ. Systemic and mucosal immune responses to sublingual or intramuscular human papilloma virus antigens in healthy female volunteers. PLoS One 2012; 7:e33736; http://dx.doi.org/10.1371/journal.pone.0033736; PMID: 22438987
   PubMed Web of Science ®Google Scholar
• Luci C, Hervouet C, Rousseau D, Holmgren J, Czerkinsky C, Anjuère F. Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin. J Immunol 2006; 176:2749 - 57; http://dx.doi.org/10.4049/jimmunol.176.5.2749; PMID: 16493030
   PubMed Web of Science ®Google Scholar
• Klein K, Mann JF, Rogers P, Shattock RJ. Polymeric penetration enhancers promote humoral immune responses to mucosal vaccines. Journal of controlled release: official journal of the Controlled Release Society 2014.
   Google Scholar
• Echchannaoui H, Bianchi M, Baud D, Bobst M, Stehle JC, Nardelli-Haefliger D. Intravaginal immunization of mice with recombinant Salmonella enterica serovar Typhimurium expressing human papillomavirus type 16 antigens as a potential route of vaccination against cervical cancer. Infect Immun 2008; 76:1940 - 51; http://dx.doi.org/10.1128/IAI.01484-07; PMID: 18332214
   PubMed Web of Science ®Google Scholar
• Domingos-Pereira S, Decrausaz L, Derré L, Bobst M, Romero P, Schiller JT, Jichlinski P, Nardelli-Haefliger D. Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice. Mucosal Immunol 2013; 6:393 - 404; http://dx.doi.org/10.1038/mi.2012.83; PMID: 22968420
   PubMed Web of Science ®Google Scholar
• Seavey MM, Mosmann TR. Estradiol-induced vaginal mucus inhibits antigen penetration and CD8(+) T cell priming in response to intravaginal immunization. Vaccine 2009; 27:2342 - 9; http://dx.doi.org/10.1016/j.vaccine.2009.02.025; PMID: 19428849
   PubMed Web of Science ®Google Scholar
• Soler E, Parez N, Passet B, Dubuquoy C, Riffault S, Pillot M, Houdebine LM, Schwartz-Cornil I. Recombinant rotavirus inner core proteins produced in the milk of transgenic rabbits confer a high level of protection after intrarectal delivery. Vaccine 2007; 25:6373 - 80; http://dx.doi.org/10.1016/j.vaccine.2007.06.011; PMID: 17629366
   PubMed Web of Science ®Google Scholar
• Alkadah A, Thiam F, Mounier M, Charpilienne A, Poncet D, Kohli E, Basset C. Different profile and distribution of antigen specific T cells induced by intranasal and intrarectal immunization with rotavirus 2/6-VLP with and without LT-R192G. Vaccine 2013; 31:1924 - 30; http://dx.doi.org/10.1016/j.vaccine.2013.02.019; PMID: 23453731
   PubMed Web of Science ®Google Scholar
• Polacino PS, Stallard V, Klaniecki JE, Pennathur S, Montefiori DC, Langlois AJ, Richardson BA, Morton WR, Benveniste RE, Hu SL. Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in Macaques. J Virol 1999; 73:8201 - 15; PMID: 10482571
   PubMed Web of Science ®Google Scholar
• Belyakov IM, Isakov D, Zhu Q, Dzutsev A, Berzofsky JA. A novel functional CTL avidity/activity compartmentalization to the site of mucosal immunization contributes to protection of macaques against simian/human immunodeficiency viral depletion of mucosal CD4+ T cells. J Immunol 2007; 178:7211 - 21; http://dx.doi.org/10.4049/jimmunol.178.11.7211; PMID: 17513770
   PubMed Web of Science ®Google Scholar
• Hu K, Dou J, Yu F, He X, Yuan X, Wang Y, Liu C, Gu N. An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice. Vaccine 2011; 29:1455 - 62; http://dx.doi.org/10.1016/j.vaccine.2010.12.031; PMID: 21185849
   PubMed Web of Science ®Google Scholar
• Griffiths KL, Stylianou E, Poyntz HC, Betts GJ, Fletcher HA, McShane H. Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice. PLoS One 2013; 8:e78312; http://dx.doi.org/10.1371/journal.pone.0078312; PMID: 24194918
   PubMed Web of Science ®Google Scholar
• Rhee JH, Lee SE, Kim SY. Mucosal vaccine adjuvants update. Clinical and experimental vaccine research 2012; 1:50-63.
   Google Scholar
• Mutsch M, Zhou W, Rhodes P, Bopp M, Chen RT, Linder T, Spyr C, Steffen R. Use of the inactivated intranasal influenza vaccine and the risk of Bell’s palsy in Switzerland. N Engl J Med 2004; 350:896 - 903; http://dx.doi.org/10.1056/NEJMoa030595; PMID: 14985487
   PubMed Web of Science ®Google Scholar
• da Hora VP, Conceição FR, Dellagostin OA, Doolan DL. Non-toxic derivatives of LT as potent adjuvants. Vaccine 2011; 29:1538 - 44; http://dx.doi.org/10.1016/j.vaccine.2010.11.091; PMID: 21163247
   PubMed Web of Science ®Google Scholar
• Nawar HF, Arce S, Russell MW, Connell TD. Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants. Infect Immun 2007; 75:621 - 33; http://dx.doi.org/10.1128/IAI.01009-06; PMID: 17118982
   PubMed Web of Science ®Google Scholar
• Didierlaurent AM, Morel S, Lockman L, Giannini SL, Bisteau M, Carlsen H, Kielland A, Vosters O, Vanderheyde N, Schiavetti F, et al. AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. J Immunol 2009; 183:6186 - 97; http://dx.doi.org/10.4049/jimmunol.0901474; PMID: 19864596
   PubMed Web of Science ®Google Scholar
• Schwarz TF, Spaczynski M, Schneider A, Wysocki J, Galaj A, Perona P, Poncelet S, Zahaf T, Hardt K, Descamps D, et al, HPV Study Group for Adult Women. Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15-55 years. Vaccine 2009; 27:581 - 7; http://dx.doi.org/10.1016/j.vaccine.2008.10.088; PMID: 19022320
   PubMed Web of Science ®Google Scholar
• Cranage MP, Fraser CA, Cope A, McKay PF, Seaman MS, Cole T, Mahmoud AN, Hall J, Giles E, Voss G, et al. Antibody responses after intravaginal immunisation with trimeric HIV-1 CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulation. Vaccine 2011; 29:1421 - 30; http://dx.doi.org/10.1016/j.vaccine.2010.12.034; PMID: 21187177
   PubMed Web of Science ®Google Scholar
• Fernandez S, Cisney ED, Ulrich RG. Enhancement of serum and mucosal immune responses to a Haemophilus influenzae Type B vaccine by intranasal delivery. Clin Vaccine Immunol 2013; 20:1690 - 6; http://dx.doi.org/10.1128/CVI.00215-13; PMID: 23986319
   PubMed Web of Science ®Google Scholar
• Arias MA, Van Roey GA, Tregoning JS, Moutaftsi M, Coler RN, Windish HP, Reed SG, Carter D, Shattock RJ. Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140. PLoS One 2012; 7:e41144; http://dx.doi.org/10.1371/journal.pone.0041144; PMID: 22829921
   PubMed Web of Science ®Google Scholar
• Huang CF, Wu TC, Chu YH, Hwang KS, Wang CC, Peng HJ. Effect of neonatal sublingual vaccination with native or denatured ovalbumin and adjuvant CpG or cholera toxin on systemic and mucosal immunity in mice. Scand J Immunol 2008; 68:502 - 10; http://dx.doi.org/10.1111/j.1365-3083.2008.02172.x; PMID: 18822109
   PubMed Web of Science ®Google Scholar
• Pesce I, Monaci E, Muzzi A, Tritto E, Tavarini S, Nuti S, De Gregorio E, Wack A. Intranasal administration of CpG induces a rapid and transient cytokine response followed by dendritic and natural killer cell activation and recruitment in the mouse lung. J Innate Immun 2010; 2:144 - 59; http://dx.doi.org/10.1159/000254948; PMID: 20375632
   PubMed Web of Science ®Google Scholar
• Jiang W, Sun R, Zhou R, Wei H, Tian Z. TLR-9 activation aggravates concanavalin A-induced hepatitis via promoting accumulation and activation of liver CD4+ NKT cells. J Immunol 2009; 182:3768 - 74; http://dx.doi.org/10.4049/jimmunol.0800973; PMID: 19265155
   PubMed Web of Science ®Google Scholar
• McNally B, Willette M, Ye F, Partida-Sanchez S, Flaño E. Intranasal administration of dsRNA analog poly(I:C) induces interferon-α receptor-dependent accumulation of antigen experienced T cells in the airways. PLoS One 2012; 7:e51351; http://dx.doi.org/10.1371/journal.pone.0051351; PMID: 23236482
   PubMed Web of Science ®Google Scholar
• Ainai A, Ichinohe T, Tamura S, Kurata T, Sata T, Tashiro M, Hasegawa H. Zymosan enhances the mucosal adjuvant activity of poly(I:C) in a nasal influenza vaccine. J Med Virol 2010; 82:476 - 84; http://dx.doi.org/10.1002/jmv.21694; PMID: 20087927
   PubMed Web of Science ®Google Scholar
• Nguyen CT, Kim SY, Kim MS, Lee SE, Rhee JH. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice. Vaccine 2011; 29:5731 - 9; http://dx.doi.org/10.1016/j.vaccine.2011.05.095; PMID: 21696869
   PubMed Web of Science ®Google Scholar
• Hong SH, Byun YH, Nguyen CT, Kim SY, Seong BL, Park S, Woo GJ, Yoon Y, Koh JT, Fujihashi K, et al. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection. Vaccine 2012; 30:466 - 74; http://dx.doi.org/10.1016/j.vaccine.2011.10.058; PMID: 22051136
   PubMed Web of Science ®Google Scholar
• Braga CJ, Rittner GM, Muñoz Henao JE, Teixeira AF, Massis LM, Sbrogio-Almeida ME, Taborda CP, Travassos LR, Ferreira LC. Paracoccidioides brasiliensis vaccine formulations based on the gp43-derived P10 sequence and the Salmonella enterica FliC flagellin. Infect Immun 2009; 77:1700 - 7; http://dx.doi.org/10.1128/IAI.01470-08; PMID: 19204092
   PubMed Web of Science ®Google Scholar
• Braga CJ, Massis LM, Sbrogio-Almeida ME, Alencar BC, Bargieri DY, Boscardin SB, Rodrigues MM, Ferreira LC. CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein. Vaccine 2010; 28:1373 - 82; http://dx.doi.org/10.1016/j.vaccine.2009.11.003; PMID: 19932669
   PubMed Web of Science ®Google Scholar
• Hjelm BE, Kilbourne J, Herbst-Kralovetz MM. TLR7 and 9 agonists are highly effective mucosal adjuvants for norovirus virus-like particle vaccines. Hum Vaccin Immunother 2013; 9:10; PMID: 24280723
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Fukushima K, Sannan T, Saito N, Takiguchi Y, Sato Y, Hasegawa H, Ishikawa K. Evaluation of the effectiveness and safety of chitosan derivatives as adjuvants for intranasal vaccines. Viral Immunol 2013; 26:133 - 42; http://dx.doi.org/10.1089/vim.2012.0057; PMID: 23509985
   PubMed Web of Science ®Google Scholar
• Zaharoff DA, Rogers CJ, Hance KW, Schlom J, Greiner JW. Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination. Vaccine 2007; 25:2085 - 94; http://dx.doi.org/10.1016/j.vaccine.2006.11.034; PMID: 17258843
   PubMed Web of Science ®Google Scholar
• Adotevi O, Vingert B, Freyburger L, Shrikant P, Lone YC, Quintin-Colonna F, Haicheur N, Amessou M, Herbelin A, Langlade-Demoyen P, et al. B subunit of Shiga toxin-based vaccines synergize with alpha-galactosylceramide to break tolerance against self antigen and elicit antiviral immunity. J Immunol 2007; 179:3371 - 9; http://dx.doi.org/10.4049/jimmunol.179.5.3371; PMID: 17709554
   PubMed Web of Science ®Google Scholar
• Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J Exp Med 2003; 198:267 - 79; http://dx.doi.org/10.1084/jem.20030324; PMID: 12874260
   PubMed Web of Science ®Google Scholar
• Kamijuku H, Nagata Y, Jiang X, Ichinohe T, Tashiro T, Mori K, Taniguchi M, Hase K, Ohno H, Shimaoka T, et al. Mechanism of NKT cell activation by intranasal coadministration of alpha-galactosylceramide, which can induce cross-protection against influenza viruses. Mucosal Immunol 2008; 1:208 - 18; http://dx.doi.org/10.1038/mi.2008.2; PMID: 19079180
   PubMed Web of Science ®Google Scholar
• Ko SY, Ko HJ, Chang WS, Park SH, Kweon MN, Kang CY. alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor. J Immunol 2005; 175:3309 - 17; http://dx.doi.org/10.4049/jimmunol.175.5.3309; PMID: 16116223
   PubMed Web of Science ®Google Scholar
• Youn HJ, Ko SY, Lee KA, Ko HJ, Lee YS, Fujihashi K, Boyaka PN, Kim SH, Horimoto T, Kweon MN, et al. A single intranasal immunization with inactivated influenza virus and alpha-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system. Vaccine 2007; 25:5189 - 98; http://dx.doi.org/10.1016/j.vaccine.2007.04.081; PMID: 17548137
   PubMed Web of Science ®Google Scholar
• Courtney AN, Thapa P, Singh S, Wishahy AM, Zhou D, Sastry J. Intranasal but not intravenous delivery of the adjuvant α-galactosylceramide permits repeated stimulation of natural killer T cells in the lung. Eur J Immunol 2011; 41:3312 - 22; http://dx.doi.org/10.1002/eji.201041359; PMID: 21818755
   PubMed Web of Science ®Google Scholar
• Kunii N, Horiguchi S, Motohashi S, Yamamoto H, Ueno N, Yamamoto S, Sakurai D, Taniguchi M, Nakayama T, Okamoto Y. Combination therapy of in vitro-expanded natural killer T cells and alpha-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma. Cancer Sci 2009; 100:1092 - 8; http://dx.doi.org/10.1111/j.1349-7006.2009.01135.x; PMID: 19302288
   PubMed Web of Science ®Google Scholar
• Yoshino N, Endo M, Kanno H, Matsukawa N, Tsutsumi R, Takeshita R, Sato S. Polymyxins as novel and safe mucosal adjuvants to induce humoral immune responses in mice. PLoS One 2013; 8:e61643; http://dx.doi.org/10.1371/journal.pone.0061643; PMID: 23593492
   PubMedGoogle Scholar
• Shin H, Iwasaki A. Generating protective immunity against genital herpes. Trends Immunol 2013; 34:487 - 94; http://dx.doi.org/10.1016/j.it.2013.08.001; PMID: 24012144
   PubMed Web of Science ®Google Scholar
• Hammerschmidt SI, Friedrichsen M, Boelter J, Lyszkiewicz M, Kremmer E, Pabst O, Förster R. Retinoic acid induces homing of protective T and B cells to the gut after subcutaneous immunization in mice. J Clin Invest 2011; 121:3051 - 61; http://dx.doi.org/10.1172/JCI44262; PMID: 21737878
   PubMed Web of Science ®Google Scholar
• Jiang T, Singh B, Li HS, Kim YK, Kang SK, Nah JW, Choi YJ, Cho CS. Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan. Biomaterials 2014; 35:2365 - 73; http://dx.doi.org/10.1016/j.biomaterials.2013.11.073; PMID: 24342722
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Pascual DW, Kiyono H. M cell-targeted mucosal vaccine strategies. Curr Top Microbiol Immunol 2012; 354:39 - 52; http://dx.doi.org/10.1007/82_2011_134; PMID: 21688209
   PubMed Web of Science ®Google Scholar
• Mohamadzadeh M, Duong T, Sandwick SJ, Hoover T, Klaenhammer TR. Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge. Proc Natl Acad Sci U S A 2009; 106:4331 - 6; http://dx.doi.org/10.1073/pnas.0900029106; PMID: 19246373
   PubMed Web of Science ®Google Scholar
• de Souza RD, Batista MT, Luiz WB, Cavalcante RC, Amorim JH, Bizerra RS, Martins EG, Ferreira LC. Bacillus subtilis spores as vaccine adjuvants: further insights into the mechanisms of action. PLoS One 2014; 9:e87454; http://dx.doi.org/10.1371/journal.pone.0087454; PMID: 24475289
   PubMedGoogle Scholar
• Haicheur N, Bismuth E, Bosset S, Adotevi O, Warnier G, Lacabanne V, Regnault A, Desaymard C, Amigorena S, Ricciardi-Castagnoli P, et al. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens. J Immunol 2000; 165:3301 - 8; http://dx.doi.org/10.4049/jimmunol.165.6.3301; PMID: 10975847
   PubMed Web of Science ®Google Scholar
• Vingert B, Adotevi O, Patin D, Jung S, Shrikant P, Freyburger L, Eppolito C, Sapoznikov A, Amessou M, Quintin-Colonna F, et al. The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits anti-tumor immunity. Eur J Immunol 2006; 36:1124 - 35; http://dx.doi.org/10.1002/eji.200535443; PMID: 16568496
   PubMed Web of Science ®Google Scholar
• Smith DC, Lord JM, Roberts LM, Tartour E, Johannes L. 1st class ticket to class I: protein toxins as pathfinders for antigen presentation. Traffic 2002; 3:697 - 704; http://dx.doi.org/10.1034/j.1600-0854.2002.31001.x; PMID: 12230467
   PubMed Web of Science ®Google Scholar
• Sandoval F, Terme M, Nizard M, Badoual C, Bureau MF, Freyburger L, Clement O, Marcheteau E, Gey A, Fraisse G, et al. Mucosal imprinting of vaccine-induced CD8(+) T cells is crucial to inhibit the growth of mucosal tumors. Science translational medicine 2013; 5:172ra20.
   Google Scholar
• Mejias MP, Ghersi G, Craig PO, Panek CA, Bentancor LV, Baschkier A, Goldbaum FA, Zylberman V, Palermo MS. Immunization with a chimera consisting of the B subunit of Shiga toxin type 2 and brucella lumazine synthase confers total protection against Shiga toxins in mice. J Immunol 2013; 191:2403 - 11; http://dx.doi.org/10.4049/jimmunol.1300999; PMID: 23918978
   PubMed Web of Science ®Google Scholar
• Gupta P, Singh MK, Singh Y, Gautam V, Kumar S, Kumar O, Dhaked RK. Recombinant Shiga toxin B subunit elicits protection against Shiga toxin via mixed Th type immune response in mice. Vaccine 2011; 29:8094 - 100; http://dx.doi.org/10.1016/j.vaccine.2011.08.040; PMID: 21856355
   PubMed Web of Science ®Google Scholar
• Pere H, Montier Y, Bayry J, Quintin-Colonna F, Merillon N, Dransart E, Badoual C, Gey A, Ravel P, Marcheteau E, et al. A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens. Blood 2011; 118:4853 - 62; http://dx.doi.org/10.1182/blood-2011-01-329656; PMID: 21908423
   PubMed Web of Science ®Google Scholar
• Johannes L, Tartour E. Correspondence to Creydt VP et al., Cytotoxic effect of Shiga toxin-2 holotoxin and its B subunit on human renal tubular epithelial cells, Microbes Infect. 8(2) (2006) 410-419. Microbes and infection / Institut Pasteur 2006; 8:2331-2.
   Google Scholar
• Samstein RM, Perica K, Balderrama F, Look M, Fahmy TM. The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles. Biomaterials 2008; 29:703 - 8; http://dx.doi.org/10.1016/j.biomaterials.2007.10.026; PMID: 18006053
   PubMed Web of Science ®Google Scholar
• Katz DE, DeLorimier AJ, Wolf MK, Hall ER, Cassels FJ, van Hamont JE, Newcomer RL, Davachi MA, Taylor DN, McQueen CE. Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen. Vaccine 2003; 21:341 - 6; http://dx.doi.org/10.1016/S0264-410X(02)00613-8; PMID: 12531630
   PubMed Web of Science ®Google Scholar
• Lawson LB, Norton EB, Clements JD. Defending the mucosa: adjuvant and carrier formulations for mucosal immunity. Curr Opin Immunol 2011; 23:414 - 20; http://dx.doi.org/10.1016/j.coi.2011.03.009; PMID: 21511452
   PubMed Web of Science ®Google Scholar
• Treanor J, Nolan C, O’Brien D, Burt D, Lowell G, Linden J, Fries L. Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjects. Vaccine 2006; 24:254 - 62; http://dx.doi.org/10.1016/j.vaccine.2005.07.088; PMID: 16129526
   PubMed Web of Science ®Google Scholar
• De Smet R, Allais L, Cuvelier C. Recent advances in oral vaccine development: Yeast-derived β-glucan particles. Hum Vaccin Immunother 2014; 10:10; http://dx.doi.org/10.4161/hv.28166; PMID: 24553259
   PubMed Web of Science ®Google Scholar
• De Smet R, Demoor T, Verschuere S, Dullaers M, Ostroff GR, Leclercq G, Allais L, Pilette C, Dierendonck M, De Geest BG, et al. beta-Glucan microparticles are good candidates for mucosal antigen delivery in oral vaccination. Journal of controlled release: official journal of the Controlled Release Society 2013; 172:671-8.
   Google Scholar
• Tamura S. Studies on the usefulness of intranasal inactivated influenza vaccines. Vaccine 2010; 28:6393 - 7; http://dx.doi.org/10.1016/j.vaccine.2010.05.019; PMID: 20493820
   PubMed Web of Science ®Google Scholar
• Neutra MR, Kozlowski PA. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 2006; 6:148 - 58; http://dx.doi.org/10.1038/nri1777; PMID: 16491139
   PubMed Web of Science ®Google Scholar
• Perrone LA, Ahmad A, Veguilla V, Lu X, Smith G, Katz JM, Pushko P, Tumpey TM. Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge. J Virol 2009; 83:5726 - 34; http://dx.doi.org/10.1128/JVI.00207-09; PMID: 19321609
   PubMed Web of Science ®Google Scholar
• Forbes EK, Sander C, Ronan EO, McShane H, Hill AV, Beverley PC, Tchilian EZ. Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J Immunol 2008; 181:4955 - 64; http://dx.doi.org/10.4049/jimmunol.181.7.4955; PMID: 18802099
   PubMed Web of Science ®Google Scholar
• Gallichan WS, Woolstencroft RN, Guarasci T, McCluskie MJ, Davis HL, Rosenthal KL. Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract. J Immunol 2001; 166:3451 - 7; http://dx.doi.org/10.4049/jimmunol.166.5.3451; PMID: 11207303
   PubMed Web of Science ®Google Scholar
• Kaufman DR, Liu J, Carville A, Mansfield KG, Havenga MJ, Goudsmit J, Barouch DH. Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination. J Immunol 2008; 181:4188 - 98; http://dx.doi.org/10.4049/jimmunol.181.6.4188; PMID: 18768876
   PubMed Web of Science ®Google Scholar
• Czerkinsky C, Holmgren J. Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues. Curr Top Microbiol Immunol 2012; 354:1 - 18; http://dx.doi.org/10.1007/82_2010_112; PMID: 21053117
   PubMed Web of Science ®Google Scholar
• Tartour E, Zitvogel L. Lung cancer: potential targets for immunotherapy. The lancet. Respir Med 2013; 1:551 - 63
   Web of Science ®Google Scholar
• Kroemer G, Zitvogel L, Galluzzi L. Victories and deceptions in tumor immunology: Stimuvax(®). Oncoimmunology 2013; 2:e23687; http://dx.doi.org/10.4161/onci.23687; PMID: 23483762
   PubMed Web of Science ®Google Scholar
• Vansteenkiste J, Zielinski M, Linder A, Dahabreh J, Gonzalez EE, Malinowski W, Lopez-Brea M, Vanakesa T, Jassem J, Kalofonos H, et al. Adjuvant MAGE-A3 immunotherapy in resected non-small-cell lung cancer: phase II randomized study results. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2013; 31:2396-403.
   Google Scholar
• Ramlau R, Quoix E, Rolski J, Pless M, Lena H, Levy E, Krzakowski M, Hess D, Tartour E, Chenard MP, et al. A phase II study of Tg4010 (Mva-Muc1-Il2) in association with chemotherapy in patients with stage III/IV Non-small cell lung cancer. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer 2008; 3:735-44.
   Google Scholar
• Li AV, Moon JJ, Abraham W, Suh H, Elkhader J, Seidman MA, Yen M, Im EJ, Foley MH, Barouch DH, et al. Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination. Science translational medicine 2013; 5:204ra130.
   Google Scholar
• Yu CI, Becker C, Wang Y, Marches F, Helft J, Leboeuf M, Anguiano E, Pourpe S, Goller K, Pascual V, et al. Human CD1c+ dendritic cells drive the differentiation of CD103+ CD8+ mucosal effector T cells via the cytokine TGF-β. Immunity 2013; 38:818 - 30; http://dx.doi.org/10.1016/j.immuni.2013.03.004; PMID: 23562160
   PubMed Web of Science ®Google Scholar
• Wakabayashi A, Nakagawa Y, Shimizu M, Moriya K, Nishiyama Y, Takahashi H. Suppression of an already established tumor growing through activated mucosal CTLs induced by oral administration of tumor antigen with cholera toxin. J Immunol 2008; 180:4000 - 10; http://dx.doi.org/10.4049/jimmunol.180.6.4000; PMID: 18322209
   PubMed Web of Science ®Google Scholar
• Bourquin C, von der Borch P, Zoglmeier C, Anz D, Sandholzer N, Suhartha N, Wurzenberger C, Denzel A, Kammerer R, Zimmermann W, et al. Efficient eradication of subcutaneous but not of autochthonous gastric tumors by adoptive T cell transfer in an SV40 T antigen mouse model. J Immunol 2010; 185:2580 - 8; http://dx.doi.org/10.4049/jimmunol.0903231; PMID: 20644173
   PubMed Web of Science ®Google Scholar
• Mullins DW, Sheasley SL, Ream RM, Bullock TN, Fu YX, Engelhard VH. Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control. J Exp Med 2003; 198:1023 - 34; http://dx.doi.org/10.1084/jem.20021348; PMID: 14530375
   PubMed Web of Science ®Google Scholar
• Kim-Schulze S, Kim HS, Wainstein A, Kim DW, Yang WC, Moroziewicz D, Mong PY, Bereta M, Taback B, Wang Q, et al. Intrarectal vaccination with recombinant vaccinia virus expressing carcinoembronic antigen induces mucosal and systemic immunity and prevents progression of colorectal cancer. J Immunol 2008; 181:8112 - 9; http://dx.doi.org/10.4049/jimmunol.181.11.8112; PMID: 19018004
   PubMed Web of Science ®Google Scholar
• Domingos-Pereira S, Derré L, Warpelin-Decrausaz L, Haefliger JA, Romero P, Jichlinski P, Nardelli-Haefliger D. Intravaginal and subcutaneous immunization induced vaccine specific CD8 T cells and tumor regression in the bladder. J Urol 2014; 191:814 - 22; http://dx.doi.org/10.1016/j.juro.2013.08.009; PMID: 23954582
   PubMed Web of Science ®Google Scholar
• Decrausaz L, Domingos-Pereira S, Duc M, Bobst M, Romero P, Schiller JT, Jichlinski P, Nardelli-Haefliger D. Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus-associated genital tumors. International journal of cancer Journal international du cancer 2011; 129:762-72.
   Google Scholar
• Kenter GG, Welters MJ, Valentijn AR, Lowik MJ, Berends-van der Meer DM, Vloon AP, Essahsah F, Fathers LM, Offringa R, Drijfhout JW, et al. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N Engl J Med 2009; 361:1838 - 47; http://dx.doi.org/10.1056/NEJMoa0810097; PMID: 19890126
   PubMed Web of Science ®Google Scholar
• Pages F. Tumor-associated immune parameters for personalized patient care. Science translational medicine 2013; 5:214fs42.
   Google Scholar
• Devaud C, Westwood JA, John LB, Flynn JK, Paquet-Fifield S, Duong CP, Yong CS, Pegram HJ, Stacker SA, Achen MG, et al. Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy. Molecular therapy: the journal of the American Society of Gene Therapy 2014; 22:18-27.
   Google Scholar
• Badoual C, Hans S, Merillon N, Van Ryswick C, Ravel P, Benhamouda N, Levionnois E, Nizard M, Si-Mohamed A, Besnier N, et al. PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer. Cancer Res 2013; 73:128 - 38; http://dx.doi.org/10.1158/0008-5472.CAN-12-2606; PMID: 23135914
   PubMed Web of Science ®Google Scholar
• Petaja T, Pedersen C, Poder A, Strauss G, Catteau G, Thomas F, Lehtinen M, Descamps D. Long-term persistence of systemic and mucosal immune response to HPV-16/18 AS04-adjuvanted vaccine in preteen/adolescent girls and young women. International journal of cancer Journal international du cancer 2011; 129:2147-57.
   Google Scholar
• Boelen A, Andeweg A, Kwakkel J, Lokhorst W, Bestebroer T, Dormans J, Kimman T. Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice. Vaccine 2000; 19:982 - 91; http://dx.doi.org/10.1016/S0264-410X(00)00213-9; PMID: 11115725
   PubMed Web of Science ®Google Scholar
• Flipse J, Wilschut J, Smit JM. Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans. Traffic 2013; 14:25 - 35; PMID: 22998156
   PubMed Web of Science ®Google Scholar
• Ray SJ, Franki SN, Pierce RH, Dimitrova S, Koteliansky V, Sprague AG, Doherty PC, de Fougerolles AR, Topham DJ. The collagen binding alpha1beta1 integrin VLA-1 regulates CD8 T cell-mediated immune protection against heterologous influenza infection. Immunity 2004; 20:167 - 79; http://dx.doi.org/10.1016/S1074-7613(04)00021-4; PMID: 14975239
   PubMed Web of Science ®Google Scholar
• Tang VA, Rosenthal KL. Intravaginal infection with herpes simplex virus type-2 (HSV-2) generates a functional effector memory T cell population that persists in the murine genital tract. J Reprod Immunol 2010; 87:39 - 44; http://dx.doi.org/10.1016/j.jri.2010.06.155; PMID: 20688399
   PubMed Web of Science ®Google Scholar
• Kelly KA, Chan AM, Butch A, Darville T. Two different homing pathways involving integrin β7 and E-selectin significantly influence trafficking of CD4 cells to the genital tract following Chlamydia muridarum infection. Am J Reprod Immunol 2009; 61:438 - 45; http://dx.doi.org/10.1111/j.1600-0897.2009.00704.x; PMID: 19392981
   PubMed Web of Science ®Google Scholar